Literature DB >> 21288848

Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature.

Anandi N Sheth1, Keri N Althoff, John T Brooks.   

Abstract

Influenza is a common cause of respiratory illness in adults infected with human immunodeficiency virus (HIV), but current knowledge about seasonal and 2009 H1N1 pandemic influenza A (H1N1pdm) virus infections in HIV-infected persons is limited. In this paper, we review the existing literature regarding influenza susceptibility, severity, and shedding in HIV-infected adults. Data show HIV infection does not significantly increase susceptibility to influenza. AIDS is associated with greater seasonal influenza-related morbidity and mortality, but the risk associated with HIV infection among those with less immune suppression is largely unknown. Immunologic compromise has been shown to increase the magnitude and duration of influenza virus shedding; however, these studies are limited within HIV-infected populations. With regards to H1N1pdm, data are even more limited. Reports raise concern of increased severity among HIV-infected persons, although this may be driven by other comorbid illnesses. Prospective studies are needed among HIV-infected persons to more definitively investigate influenza susceptibility, severity, and shedding.

Entities:  

Mesh:

Year:  2011        PMID: 21288848      PMCID: PMC4990828          DOI: 10.1093/cid/ciq110

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  45 in total

1.  Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient.

Authors:  David M Weinstock; Larisa V Gubareva; Gianna Zuccotti
Journal:  N Engl J Med       Date:  2003-02-27       Impact factor: 91.245

2.  Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis.

Authors:  A I Klimov; E Rocha; F G Hayden; P A Shult; L F Roumillat; N J Cox
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

3.  Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients.

Authors:  Hikaru Yamanaka; Katsuji Teruya; Mari Tanaka; Yoshimi Kikuchi; Takao Takahashi; Satoshi Kimura; Shinichi Oka
Journal:  J Acquir Immune Defic Syndr       Date:  2005-06-01       Impact factor: 3.731

4.  Clinical manifestations of influenza in HIV-infected individuals.

Authors:  D J Skiest; P Kaplan; T Machala; L Boney; J Luby
Journal:  Int J STD AIDS       Date:  2001-10       Impact factor: 1.359

5.  Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.

Authors:  J C King; J Treanor; P E Fast; M Wolff; L Yan; D Iacuzio; B Readmond; D O'Brien; K Mallon; W E Highsmith; J S Lambert; R B Belshe
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

6.  Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season.

Authors:  H M Radwan; S H Cheeseman; K K Lai; R T Ellison III
Journal:  Clin Infect Dis       Date:  2000-08       Impact factor: 9.079

7.  Behaviour of the pandemic H1N1 influenza virus in Andalusia, Spain, at the onset of the 2009-10 season.

Authors:  J M Mayoral Cortes; L Puell Gómez; E Pérez Morilla; V Gallardo García; E Duran Pla; J C Fernandez Merino; J Guillén Enriquez; J C Carmona; G Anderica; I Mateos; J M Navarro Marí; M Pérez Ruiz; A Daponte
Journal:  Euro Surveill       Date:  2009-12-10

8.  Preliminary analysis of the pandemic H1N1 influenza on Reunion Island (Indian Ocean): surveillance trends (July to mid-September 2009).

Authors:  F Thouillot; C Do; E Balleydier; E Rachou; F Staikowsky; P Morbidelli; Y Jacques-Antoine; A Bourde; M Lagrange-Xelot; P Poubeau; A Winer; Ba Gauzere; A Michault; Mc Jaffar-Bandjee; G Henrion; L Filleul; E D'Ortenzio
Journal:  Euro Surveill       Date:  2009-10-22

9.  Critically Ill patients with 2009 influenza A(H1N1) in Mexico.

Authors:  Guillermo Domínguez-Cherit; Stephen E Lapinsky; Alejandro E Macias; Ruxandra Pinto; Lourdes Espinosa-Perez; Alethse de la Torre; Manuel Poblano-Morales; Jose A Baltazar-Torres; Edgar Bautista; Abril Martinez; Marco A Martinez; Eduardo Rivero; Rafael Valdez; Guillermo Ruiz-Palacios; Martín Hernández; Thomas E Stewart; Robert A Fowler
Journal:  JAMA       Date:  2009-10-12       Impact factor: 56.272

10.  Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.

Authors:  Seema Jain; Laurie Kamimoto; Anna M Bramley; Ann M Schmitz; Stephen R Benoit; Janice Louie; David E Sugerman; Jean K Druckenmiller; Kathleen A Ritger; Rashmi Chugh; Supriya Jasuja; Meredith Deutscher; Sanny Chen; John D Walker; Jeffrey S Duchin; Susan Lett; Susan Soliva; Eden V Wells; David Swerdlow; Timothy M Uyeki; Anthony E Fiore; Sonja J Olsen; Alicia M Fry; Carolyn B Bridges; Lyn Finelli
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

View more
  35 in total

1.  Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.

Authors:  Yanmei Hu; Jiantao Zhang; Rami Ghassan Musharrafieh; Chunlong Ma; Raymond Hau; Jun Wang
Journal:  Antiviral Res       Date:  2017-08-02       Impact factor: 5.970

2.  Sometimes, more is better.

Authors:  Edgar Turner Overton
Journal:  J Infect Dis       Date:  2012-01-24       Impact factor: 5.226

3.  Evaluation of Performance Characteristics of Panther Fusion Assays for Detection of Respiratory Viruses from Nasopharyngeal and Lower Respiratory Tract Specimens.

Authors:  Soya S Sam; Angela M Caliendo; Jessica Ingersoll; Deborah Abdul-Ali; Charles E Hill; Colleen S Kraft
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

4.  Mortality Associated With Seasonal and Pandemic Influenza Among Pregnant and Nonpregnant Women of Childbearing Age in a High-HIV-Prevalence Setting-South Africa, 1999-2009.

Authors:  Stefano Tempia; Sibongile Walaza; Adam L Cohen; Claire von Mollendorf; Jocelyn Moyes; Johanna M McAnerney; Cheryl Cohen
Journal:  Clin Infect Dis       Date:  2015-06-09       Impact factor: 9.079

5.  Pigs with Severe Combined Immunodeficiency Are Impaired in Controlling Influenza A Virus Infection.

Authors:  Daniela S Rajao; Crystal L Loving; Emily H Waide; Phillip C Gauger; Jack C M Dekkers; Christopher K Tuggle; Amy L Vincent
Journal:  J Innate Immun       Date:  2016-12-17       Impact factor: 7.349

6.  Antigenic Restimulation of Virus-Specific Memory CD8+ T Cells Requires Days of Lytic Protein Accumulation for Maximal Cytotoxic Capacity.

Authors:  Stephen A Migueles; Daniel C Rogan; Noah V Gavil; Elizabeth P Kelly; Sushila A Toulmin; Lawrence T Wang; Justin Lack; Addison J Ward; Patrick F Pryal; Amanda K Ludwig; Renata G Medina; Benjamin J Apple; Christina N Toumanios; April L Poole; Catherine A Rehm; Sara E Jones; C Jason Liang; Mark Connors
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

7.  HIV infection Worsens Age-Associated Defects in Antibody Responses to Influenza Vaccine.

Authors:  Varghese K George; Suresh Pallikkuth; Anita Parmigiani; Maria Alcaide; Margaret Fischl; Kristopher L Arheart; Savita Pahwa
Journal:  J Infect Dis       Date:  2015-01-02       Impact factor: 5.226

8.  Infection control best practices in clinical research in resource-limited settings.

Authors:  Catherine Godfrey; Jeffrey T Schouten
Journal:  J Acquir Immune Defic Syndr       Date:  2014-01-01       Impact factor: 3.731

Review 9.  Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.

Authors:  Meghan E Fitzpatrick; Ken M Kunisaki; Alison Morris
Journal:  AIDS       Date:  2018-01-28       Impact factor: 4.177

10.  Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study.

Authors:  Tochukwu Raphael Abadom; Adrian D Smith; Stefano Tempia; Shabir A Madhi; Cheryl Cohen; Adam L Cohen
Journal:  Vaccine       Date:  2016-10-06       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.